Skip to Main content Skip to Navigation
Journal articles

Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction.

Complete list of metadata

https://hal.univ-lorraine.fr/hal-03362290
Contributor : Erwan BOZEC Connect in order to contact the contributor
Submitted on : Friday, October 1, 2021 - 5:03:07 PM
Last modification on : Monday, August 29, 2022 - 10:14:36 AM
Long-term archiving on: : Sunday, January 2, 2022 - 7:47:53 PM

Files

GALACTIC_HF_LVEF_editorial.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Collections

Citation

João Pedro Ferreira. Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction.. Journal of the American College of Cardiology, Elsevier, 2021, 78 (2), pp.109-111. ⟨10.1016/j.jacc.2021.04.077⟩. ⟨hal-03362290⟩

Share

Metrics

Record views

31

Files downloads

100